4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Humacyte, Inc. (HUMA) operates in the Biotechnology industry and is headquartered in Durham, United States with about 184 employees. Its market capitalization is roughly $190 million. In the fiscal year ended 2025-12-31, HUMA reported $2M in revenue and ($41M) in net income.
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
Interactive charts & full statements → Open the HUMA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $0M | $0M | $0M | — |
| Gross Profit | ($8M) | $0M | — | — | — |
| Operating Income (EBIT) | ($108M) | ($114M) | ($100M) | ($85M) | — |
| Net Income | ($41M) | ($149M) | ($111M) | ($12M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $1M | $0M | $0M | — |
| Gross Profit | ($2M) | ($9M) | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($29M) | ($31M) | ($24M) | ($30M) | ($23M) | — |
| Net Income | ($18M) | ($25M) | ($18M) | ($38M) | $39M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | $0M | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $116M | $138M | $128M | $204M | — |
| Total Liabilities | $113M | $190M | $115M | $87M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HUMA viewer.
About TickerBase · Data methodology & sources